Compare

Enovix/$ENVX

1D1W1M3M6MYTD1Y5YMAX

About Enovix

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.
Ticker
$ENVX
Primary listing
NASDAQ
Employees
664

Enovix Metrics

BasicAdvanced
$301M
-
-$0.73
2.39
-

What the Analysts think about Enovix

Analyst ratings (Buy, Hold, Sell) for Enovix stock.
Analyst projections of the future price of Enovix stock.

Bulls say / Bears say

Commercial demand is beginning to turn into firm orders: Enovix secured a 100,000-battery drone order for first-half 2027 delivery and a separate initial production order for its MX1-B01 cell after successful field trials. (Enovix, GlobeNewswire)
Q3 revenue was $11 million, up 38% year on year and above the $9 million–$10 million guidance range, marking the sixth consecutive quarter of year-on-year growth. (GlobeNewswire)
Enovix retired $128 million face value of 2030 notes for $81.4 million, reducing debt by $46.6 million, and cut annual costs by about $8.5 million through restructuring. These steps lower its cost base as it shifts resources towards the Korean business. (GlobeNewswire)
The smartphone programme has suffered a setback: Enovix said its pre-AI-2 cell did not meet the latest energy-density target, so it will not proceed to system-level field testing with those units and is focusing silicon-anode development on smart eyewear. (GlobeNewswire)
Near-term sales guidance has weakened: Q4 revenue is forecast at $9 million–$10 million, 12%–20% below the prior-year quarter’s $11.3 million, despite Q3 growth. (GlobeNewswire)
Enovix is still burning substantial cash: Q3 operating cash outflow was about $29.2 million and free cash flow was negative $33.1 million, while Q4 non-GAAP operating losses are forecast at $28 million–$31 million. (Quantisnow, GlobeNewswire)
Data summarised monthly by Lightyear AI. Last updated on 12 Nov 2026.

Enovix Financial Performance

Revenues and expenses
Income statement
AnnuallyQuarterly
2023
YoY growth
Revenue
Net income
Profit margin

Enovix Earnings Performance

Company profitability
Earnings per share
AnnuallyQuarterly
2020
2021
2022
2023
2024
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.